17 results on '"Menger, N."'
Search Results
2. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
- Author
-
Ohla, K, Green, T, Hannum, M E, Bakke, A J, Moein, S T, Tognetti, A, Postma, E M, Pellegrino, R, Hwang, D L D, Albayay, J, Koyama, S, Nolden, A A, Thomas-Danguin, T, Mucignat-Caretta, C, Menger, N S, Croijmans, I, Öztürk, L, Yanık, H, Pierron, D, Pereda-Loth, V, Nunez-Parra, A, Martinez Pineda, A M, Gillespie, D, Farruggia, M C, Cecchetto, C, Fornazieri, M A, Philpott, C, Voznessenskaya, V, Cooper, K W, Rohlfs Dominguez, P, Calcinoni, O, de Groot, J, Boesveldt, S, Bhutani, S, Weir, E M, Exten, C, Joseph, P V, Hayes, J E, Niv, M Y, Leerstoel Smeets, and Social-cognitive and interpersonal determinants of behaviour
- Subjects
parosmia ,post-COVID ,Otorhinolaryngology ,phantosmia ,public health ,smell ,olfaction disorders ,long COVID - Abstract
Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the emergence of Omicron, had estimated prevalence of ~40% to 75%. Chemosensory impairments affect physical and mental health, and dietary behavior. Thus, it is critical to understand the rate and time course of smell recovery. The aim of this cohort study was to characterize smell function and recovery up to 11 months post COVID-19 infection. Methods: This longitudinal survey of individuals suffering COVID-19-related smell loss assessed disease symptoms and gustatory and olfactory function. Participants (n=12,313) who completed an initial survey (S1) about respiratory symptoms, chemosensory function and COVID-19 diagnosis between April and September 2020, were invited to complete a follow-up survey (S2). Between September 2020 and February 2021, 27.5% participants responded (n=3,386), with 1,468 being diagnosed with COVID-19 and suffering co-occurring smell and taste loss at the beginning of their illness. Results: At follow-up (median time since COVID-19 onset ~200 days), ~60% of women and ~48% of men reported less than 80% of their pre-illness smell ability. Taste typically recovered faster than smell, and taste loss rarely persisted if smell recovered. Prevalence of parosmia and phantosmia was ~10% of participants in S1 and increased substantially in S2: ~47% for parosmia and ~25% for phantosmia. Persistent smell impairment was associated with more symptoms overall, suggesting it may be a key marker of long-COVID illness. The ability to smell during COVID-19 was rated slightly lower by those who did not eventually recover their pre-illness ability to smell at S2. Conclusions: While smell ability improves for many individuals who lost it during acute COVID-19, the prevalence of parosmia and phantosmia increases substantially over time. Olfactory dysfunction is associated with broader persistent symptoms of COVID-19, and may last for many months following acute COVID-19. Taste loss in the absence of smell loss is rare. Persistent qualitative smell symptoms are emerging as common long-term sequelae; more research into treatment options is strongly warranted given that even conservative estimates suggest millions of individuals may experience parosmia following COVID-19. Healthcare providers worldwide need to be prepared to treat post COVID-19 secondary effects on physical and mental health. Trial registration: This project was pre-registered at OSF 1.
- Published
- 2022
3. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
- Author
-
Leerstoel Smeets, Social-cognitive and interpersonal determinants of behaviour, Ohla, K, Green, T, Hannum, M E, Bakke, A J, Moein, S T, Tognetti, A, Postma, E M, Pellegrino, R, Hwang, D L D, Albayay, J, Koyama, S, Nolden, A A, Thomas-Danguin, T, Mucignat-Caretta, C, Menger, N S, Croijmans, I, Öztürk, L, Yanık, H, Pierron, D, Pereda-Loth, V, Nunez-Parra, A, Martinez Pineda, A M, Gillespie, D, Farruggia, M C, Cecchetto, C, Fornazieri, M A, Philpott, C, Voznessenskaya, V, Cooper, K W, Rohlfs Dominguez, P, Calcinoni, O, de Groot, J, Boesveldt, S, Bhutani, S, Weir, E M, Exten, C, Joseph, P V, Hayes, J E, Niv, M Y, Leerstoel Smeets, Social-cognitive and interpersonal determinants of behaviour, Ohla, K, Green, T, Hannum, M E, Bakke, A J, Moein, S T, Tognetti, A, Postma, E M, Pellegrino, R, Hwang, D L D, Albayay, J, Koyama, S, Nolden, A A, Thomas-Danguin, T, Mucignat-Caretta, C, Menger, N S, Croijmans, I, Öztürk, L, Yanık, H, Pierron, D, Pereda-Loth, V, Nunez-Parra, A, Martinez Pineda, A M, Gillespie, D, Farruggia, M C, Cecchetto, C, Fornazieri, M A, Philpott, C, Voznessenskaya, V, Cooper, K W, Rohlfs Dominguez, P, Calcinoni, O, de Groot, J, Boesveldt, S, Bhutani, S, Weir, E M, Exten, C, Joseph, P V, Hayes, J E, and Niv, M Y
- Published
- 2022
4. Creating an uncanny valley : effect with eye size
- Author
-
Menger, N., Menger, N., Menger, N., and Menger, N.
- Published
- 2019
5. Design of an Intelligent, Modular IGBT/SiC Inverter Platform up to 400 kW for Fast Realization of New Test-Bench Concepts
- Author
-
Stoß, J., Frank, S., Menger, N., Sommer, F., Gast, M., Decker, S., Liske, A., and Hiller, M.
- Subjects
ddc:000 ,Computer science, information & general works - Abstract
This paper presents an intelligent, modular two level, three phase inverter platform for up to 1200 V DC-link voltage and 400 kW continuous power at 10 kHz switching frequency. It features an integrated signal processing system and various sensors, which allow standalone as well as cross-linked operation. Customizable software of the signal processing system allows easy adaption to different applications such as Active-Front-End (AFE), DC/DC-converters, Dual-Active-Bridges or Drive Inverters. Focus of this paper is a design guideline for an inverter platform which fulfills requirements of various applications with regard to sensor setup, control, failure management and monitoring. Design goal of the platform is a fast setup of new testbench concepts for academic research and novel applications.
- Published
- 2021
6. The role of conscious awareness in olfactory conditioning
- Author
-
Menger, N., Pavlov, Y., and Kotchoubey, B.
- Published
- 2023
- Full Text
- View/download PDF
7. Neural signatures of contingency awareness
- Author
-
Pavlov, Y., Menger, N., Keil, A., and Kotchoubey, B.
- Published
- 2023
- Full Text
- View/download PDF
8. The cytoskeleton-associated neuronal calcium-binding protein caldendrin is expressed in a subset of amacrine, bipolar and ganglion cells of the rat retina
- Author
-
Menger, N., Seidenbecher, C. I., Gundelfinger, E. D., and Kreutz, M.R.
- Published
- 1999
- Full Text
- View/download PDF
9. Immune-mediated retinopathy in a patient with stiff-man syndrome
- Author
-
Steffen, H., Menger, N., Richter, W., Nölle, B., Krastel, H., Stayer, C., Kolling, G. H., Wässle, H., and Meinck, H.-M.
- Published
- 1999
- Full Text
- View/download PDF
10. EXPRESSION AND SUBCELLULAR LOCALIZATION OF THE NOVEL NEURONAL CALCIUM-BINDING PROTEIN CALDENDRIN
- Author
-
Seidenbecher, C I, Hoffmann, B, Bockmann, J, Böckers, T M, Menger, N, Gundelfinger, E D, and Kreutz, M R
- Published
- 1999
11. Chewing gum and lozenges as delivery systems for noscapine
- Author
-
Norgaard Jensen, L., Christrup, Lona Louring, Menger, N., Bundgaard, H., Norgaard Jensen, L., Christrup, Lona Louring, Menger, N., and Bundgaard, H.
- Abstract
Chewing gum and lozenges were evaluated as delivery systems for noscapine with the aim of developing improved antitussive preparations. The formulations studied were prepared with both the water-soluble hydrochloride salt of noscapine and with the poorly soluble embonate salt and noscapine free base. The release characteristics of the preparations were evaluated both in vitro and in vivo, and their taste properties examined. Only the formulations containing noscapine base were without any appreciable taste. Chewing gum containing this compound showed, however, a low level of drug release both in vitro and in vivo and is therefore not a suitable dosage form. Only a lozenge formulation containing noscapine base fulfilled the requirements of taste acceptability and adequate release properties.
- Published
- 1991
12. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss.
- Author
-
Ohla K, Veldhuizen MG, Green T, Hannum ME, Bakke AJ, Moein ST, Tognetti A, Postma EM, Pellegrino R, Hwang DLD, Albayay J, Koyama S, Nolden AA, Thomas-Danguin T, Mucignat-Caretta C, Menger NS, Croijmans I, Ã-ztà Rk L, YanÄ K H, Pierron D, Pereda-Loth V, Nunez-Parra A, Martinez Pineda AM, Gillespie D, Farruggia MC, Cecchetto C, Fornazieri MA, Philpott C, Voznessenskaya V, Cooper KW, Rohlfs Dominguez P, Calcinoni O, de Groot J, Boesveldt S, Bhutani S, Weir EM, Exten C, Joseph PV, Parma V, Hayes JE, and Niv MY
- Subjects
- Male, Humans, Female, Smell, Anosmia etiology, SARS-CoV-2, Cohort Studies, COVID-19 Testing, Follow-Up Studies, Post-Acute COVID-19 Syndrome, COVID-19 complications, Ageusia, Olfaction Disorders epidemiology, Olfaction Disorders etiology, Olfaction Disorders diagnosis
- Abstract
Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the emergence of Omicron, had estimated prevalence of ~40% to 75%. Chemosensory impairments affect physical and mental health, and dietary behavior. Thus, it is critical to understand the rate and time course of smell recovery. The aim of this cohort study was to characterize smell function and recovery up to 11 months post COVID-19 infection., Methods: This longitudinal survey of individuals suffering COVID-19-related smell loss assessed disease symptoms and gustatory and olfactory function. Participants (n=12,313) who completed an initial survey (S1) about respiratory symptoms, chemosensory function and COVID-19 diagnosis between April and September 2020, were invited to complete a follow-up survey (S2). Between September 2020 and February 2021, 27.5% participants responded (n=3,386), with 1,468 being diagnosed with COVID-19 and suffering co-occurring smell and taste loss at the beginning of their illness., Results: At follow-up (median time since COVID-19 onset ~200 days), ~60% of women and ~48% of men reported less than 80% of their pre-illness smell ability. Taste typically recovered faster than smell, and taste loss rarely persisted if smell recovered. Prevalence of parosmia and phantosmia was ~10% of participants in S1 and increased substantially in S2: ~47% for parosmia and ~25% for phantosmia. Persistent smell impairment was associated with more symptoms overall, suggesting it may be a key marker of long-COVID illness. The ability to smell during COVID-19 was rated slightly lower by those who did not eventually recover their pre-illness ability to smell at S2., Conclusions: While smell ability improves for many individuals who lost it during acute COVID-19, the prevalence of parosmia and phantosmia increases substantially over time. Olfactory dysfunction is associated with broader persistent symptoms of COVID-19, and may last for many months following acute COVID-19. Taste loss in the absence of smell loss is rare. Persistent qualitative smell symptoms are emerging as common long-term sequelae; more research into treatment options is strongly warranted given that even conservative estimates suggest millions of individuals may experience parosmia following COVID-19. Healthcare providers worldwide need to be prepared to treat post COVID-19 secondary effects on physical and mental health.
- Published
- 2022
- Full Text
- View/download PDF
13. Morphological and Molecular Characterization of Orchid Fruit Development.
- Author
-
Dirks-Mulder A, Ahmed I, Uit Het Broek M, Krol L, Menger N, Snier J, van Winzum A, de Wolf A, Van't Wout M, Zeegers JJ, Butôt R, Heijungs R, van Heuven BJ, Kruizinga J, Langelaan R, Smets EF, Star W, Bemer M, and Gravendeel B
- Abstract
Efficient seed dispersal in flowering plants is enabled by the development of fruits, which can be either dehiscent or indehiscent. Dehiscent fruits open at maturity to shatter the seeds, while indehiscent fruits do not open and the seeds are dispersed in various ways. The diversity in fruit morphology and seed shattering mechanisms is enormous within the flowering plants. How these different fruit types develop and which molecular networks are driving fruit diversification is still largely unknown, despite progress in eudicot model species. The orchid family, known for its astonishing floral diversity, displays a huge variation in fruit dehiscence types, which have been poorly investigated. We undertook a combined approach to understand fruit morphology and dehiscence in different orchid species to get more insight into the molecular network that underlies orchid fruit development. We describe fruit development in detail for the epiphytic orchid species Erycina pusilla and compare it to two terrestrial orchid species: Cynorkis fastigiata and Epipactis helleborine . Our anatomical analysis provides further evidence for the split carpel model, which explains the presence of three fertile and three sterile valves in most orchid species. Interesting differences were observed in the lignification patterns of the dehiscence zones. While C. fastigiata and E. helleborine develop a lignified layer at the valve boundaries, E. pusilla fruits did not lignify at these boundaries, but formed a cuticle-like layer instead. We characterized orthologs of fruit-associated MADS-domain transcription factors and of the Arabidopsis dehiscence-related genes INDEHISCENT (IND)/HECATE 3 (HEC3), REPLUMLESS (RPL) and SPATULA (SPT)/ALCATRAZ (ALC) in E. pusilla , and found that the key players of the eudicot fruit regulatory network appear well-conserved in monocots. Protein-protein interaction studies revealed that MADS-domain complexes comprised of FRUITFULL (FUL), SEPALLATA (SEP) and AGAMOUS (AG) /SHATTERPROOF (SHP) orthologs can also be formed in E. pusilla , and that the expression of HEC3, RPL , and SPT can be associated with dehiscence zone development similar to Arabidopsis. Our expression analysis also indicates differences, however, which may underlie fruit divergence.
- Published
- 2019
- Full Text
- View/download PDF
14. Morphological and physiological properties of the A17 amacrine cell of the rat retina.
- Author
-
Menger N and Wässle H
- Subjects
- Animals, Calcium Channels drug effects, Calcium Channels metabolism, Cell Size drug effects, Cell Size physiology, Dendrites drug effects, Fluorescent Dyes, Isoquinolines, Membrane Potentials drug effects, Membrane Potentials physiology, Patch-Clamp Techniques statistics & numerical data, Photic Stimulation, Potassium Channels drug effects, Potassium Channels metabolism, Rats, Rats, Inbred Strains, Receptors, GABA drug effects, Receptors, GABA metabolism, Receptors, Glutamate drug effects, Receptors, Glutamate metabolism, Receptors, Glycine drug effects, Receptors, Glycine metabolism, Retina drug effects, Vision, Ocular drug effects, Biotin analogs & derivatives, Dendrites physiology, Dendrites ultrastructure, Retina cytology, Retina physiology, Vision, Ocular physiology
- Abstract
In addition to the well-studied AII amacrine cell, there is another amacrine cell type participating in the rod pathway of the mammalian retina. In cat, this cell is called the A17 amacrine cell, and in rabbits, it is called the indoleamine-accumulating amacrine cell (S1 and S2); however, the presence of the corresponding cell type has not yet been described in detail for the rat retina. To this end, we injected amacrine cells with Neurobiotin in vertical retinal slices. After histological processing, we were able to reconstruct the morphology of a wide-field amacrine cell which showed characteristics of A17 and S1/S2 amacrine cells. The rat wide-field amacrine cells exhibited the same stratification pattern, their dendrites bore varicosities and ramified in sublamina 5 of the inner plexiform layer (IPL), and they were dye-coupled to other amacrine cells. To determine whether those amacrine cells shared electrophysiological characteristics as well, we performed whole-cell patch-clamp recordings and examined their voltage-activated currents and neurotransmitter-induced currents. We never observed voltage-gated Na+ currents and spike-like potentials upon depolarization by current injection in these cells. We identified GABA- and glycine-sensitive Cl- currents that could be blocked by bicuculline and strychnine, respectively. We also observed kainate- and AMPA-activated currents, which could be inhibited by the application of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). Finally, a 400-ms full-field light stimulus was used to characterize the light responses of A17 amacrine cells. The light ON-induced inward current could be suppressed by the application of 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide (NBQX), while the majority of the light OFF-induced current was inhibited by bicuculline and reduced to a smaller extent by NBQX. CPP, an NMDA blocker, had no effect on the light response of rat A17 amacrine cells.
- Published
- 2000
- Full Text
- View/download PDF
15. Glycinergic amacrine cells of the rat retina.
- Author
-
Menger N, Pow DV, and Wässle H
- Subjects
- Animals, Carrier Proteins physiology, Cell Count, Fluorescent Antibody Technique, Fluorescent Dyes, Glycine metabolism, Glycine Plasma Membrane Transport Proteins, Immunohistochemistry, In Vitro Techniques, Isoquinolines, Rats, Retina cytology, Amino Acid Transport Systems, Neutral, Glycine physiology, Neurons physiology, Retina physiology
- Abstract
Physiological studies of neurons of the inner retina, e.g., of amacrine cells, are now possible in a mammalian retinal slice preparation. The present anatomical study characterizes glycinergic amacrine cells of the rat retina and thus lays the ground for such future physiological and pharmacological experiments. Rat retinae were immunolabeled with antibodies against glycine and the glycine transporter-1 (GLYT-1), respectively. Glycine immunoreactivity was found in approximately 50% of the amacrine and 25% of the bipolar cells. GLYT-1 immunoreactivity was restricted to glycinergic amacrine cells. They were morphologically characterized by the intracellular injection of Lucifer Yellow followed by GLYT-1 immunolabeling. Eight different types of glycinergic amacrine cells could be distinguished. They were all small-field amacrine cells with bushy dendritic trees terminating at different levels within the inner plexiform layer. The well-known AII amacrine cell was encountered most frequently. From our measurements of the dendritic field sizes and the density of glycinergic cells, we estimate that there are enough glycinergic amacrine cells available to make sure that all eight types and possibly more tile the retina regularly with their dendritic fields.
- Published
- 1998
- Full Text
- View/download PDF
16. Sensitivity of central units in the goldfish, Carassius auratus, to transient hydrodynamic stimuli.
- Author
-
Mogdans J, Bleckmann H, and Menger N
- Subjects
- Animals, Brain Mapping, Evoked Potentials, Somatosensory physiology, Neurons physiology, Orientation physiology, Swimming physiology, Water Movements, Goldfish physiology, Mechanoreceptors physiology, Medulla Oblongata physiology
- Abstract
This study describes the discharges of central units in the medulla of the goldfish, Carassius auratus, to hydrodynamic stimuli received by the lateral line. We stimulated the animal with a small object moving in the water and recorded activity of 85 medullary lateral line units in response to different motion directions and to various object distances, velocities, accelerations and sizes. All but one unit increased discharge rate when the moving object passed the fish laterally. Five response types were distinguished based on temporal patterns of unit responses. Ten units were recorded which encoded motion direction by different temporal discharge patterns. In general, discharge rates decreased when object distance was increased and when object speed was decreased. When object size was decreased, discharge rates decreased systematically in one group of units, but they were comparable for all but the smallest object tested in a second group of units. Units responded about equally well whether an object was moved at a constant velocity or was accelerated when it passed the fish. The data indicate that medullary lateral line units in the goldfish can encode motion direction but are not tuned to other aspects of an object moving in the water. The functional properties of units in the medulla of goldfish are similar to those reported for medullary units in the catfish Ancistrus sp., suggesting that the central mechanisms for processing complex hydrodynamic stimuli may be quite similar in fish species that occupy habitats with different hydrodynamic conditions.
- Published
- 1997
- Full Text
- View/download PDF
17. Chewing gum and lozenges as delivery systems for noscapine.
- Author
-
Jensen LN, Christrup LL, Menger N, and Bundgaard H
- Subjects
- Chewing Gum, Drug Carriers, Humans, Solubility, Tablets, Noscapine administration & dosage
- Abstract
Chewing gum and lozenges were evaluated as delivery systems for noscapine with the aim of developing improved antitussive preparations. The formulations studied were prepared with both the water-soluble hydrochloride salt of noscapine and with the poorly soluble embonate salt and noscapine free base. The release characteristics of the preparations were evaluated both in vitro and in vivo, and their taste properties examined. Only the formulations containing noscapine base were without any appreciable taste. Chewing gum containing this compound showed, however, a low level of drug release both in vitro and in vivo and is therefore not a suitable dosage form. Only a lozenge formulation containing noscapine base fulfilled the requirements of taste acceptability and adequate release properties.
- Published
- 1991
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.